Molecular Weight:
0
Density:
1.14g/cm3
Boiling Point:
506.7°Cat760mmHg
Flash Point:
260.2°C
Refractive index:
1.583
Usage:
A novel steroidal inhibitor of human Cytochrome P450(17a-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer.
*The following content is generated by AI and is for reference only.
Overview
Abiraterone Acetate (CAS: 154028-92-7, Formula: C23H30NO2) is a potent inhibitor of CYP17A1 synthesized via advanced chemical coupling. It serves as a critical precursor for androgen deprivation therapy.
Application
- Oncology manufacturing for metastatic castration-resistant prostate cancer.
- R&D synthesis of novel hormonal agents targeting androgen receptor pathways.
- API production for combination therapies with prednisone.
Precautions
Strictly contraindicated in pregnancy due to teratogenic risks. Store below 25°C in dry, light-proof environments. Personnel must utilize PPE to prevent dermal exposure during handling.